Trial compares heart implant, warfarin for AF patients

03/1/2013 | MassDevice.com (Boston)

In patients with atrial fibrillation, Boston Scientific's Watchman heart implant performed better than the anticoagulant warfarin in terms of quality-of-life indicators after one year, according to a study published in the Journal of the American College of Cardiology. The study, however, also found that patients who had the implant had a higher risk for serious bleeding.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID